Selective Allosteric Antibodies to the Insulin Receptor for the Treatment of Hyperglycemic and Hypoglycemic Disorders

Many therapeutic monoclonal antibodies act as antagonists to receptors by targeting and blocking the natural ligand binding site (orthosteric site). In contrast, the use of antibodies to target receptors at allosteric sites (distinct from the orthosteric site) has not been extensively studied. This...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Diabetes Sci Technol
Hauptverfasser: Issafras, Hassan, Bedinger, Daniel H., Corbin, John A., Goldfine, Ira D., Bhaskar, Vinay, White, Mark L., Rubin, Paul, Scannon, Patrick J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2014
Schlagworte:
Review Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4764207/
https://ncbi.nlm.nih.gov/pubmed/24876415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296814529886
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge